1型和2型糖尿病患者肾病及终末期肾病的危险因素水平范围、风险控制与时间趋势
研究基于瑞典国家糖尿病登记中701,622例糖尿病患者和2,738,137例对照,分析糖尿病肾病与终末期肾病(ESKD)的趋势、最佳危险因素水平及多因素风险控制。结果显示糖尿病肾病发病率持续下降,而ESKD发病率在2007年前下降后上升;2型糖尿病所有危险因素达标者ESKD的HR为1.60(95%CI 1.49-1.71),1型糖尿病为6.10(95%CI 4.69-7.93)。
要点
- 糖尿病肾病发病率显著下降,但ESKD发病率在2007年后上升。
- 2型糖尿病危险因素全部达标者ESKD的HR为1.60(95%CI 1.49-1.71)。
- 1型糖尿病危险因素全部达标者ESKD的HR为6.10(95%CI 4.69-7.93)。
核心结论
- 糖尿病肾病发病率显著下降,而ESKD发病率上升。
- 低于目标水平的传统和可改变危险因素与较低结局风险相关,尤其收缩压和糖化血红蛋白。
研究设计与样本
- 研究纳入瑞典国家糖尿病登记中701,622例糖尿病患者和2,738,137例对照。
- 采用标准化发病率分析趋势,使用Cox回归评估超额风险、最佳危险因素水平及基于危险因素数量的风险。
主要发现
- ESKD发病率在糖尿病患者和非糖尿病患者中均先下降至2007年,之后上升,而糖尿病肾病在整个随访期间下降。
- 在糖尿病患者中,基线糖化血红蛋白、收缩压、甘油三酯和BMI与结局相关。
- 2型糖尿病所有纳入危险因素达标者ESKD的HR为1.60(95%CI 1.49-1.71),1型糖尿病为6.10(95%CI 4.69-7.93),均与对照比较。
- 与对照相比,2型糖尿病ESKD超额风险的HR为2.32(95%CI 2.30-2.35),1型糖尿病为10.92(95%CI 10.15-11.75)。
- 每项未达标危险因素使结局风险呈阶梯式增加。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To investigate trends, optimal levels for cardiometabolic risk factors, and multifactorial risk control in diabetic nephropathy and end-stage kidney disease (ESKD) in patients with diabetes and matched control subjects. RESEARCH DESIGN AND METHODS: This study included 701,622 patients with diabetes from the Swedish National Diabetes Register and 2,738,137 control subjects. Trends were analyzed with standardized incidence rates. Cox regression was used to assess excess risk, optimal risk factor levels, and risk according to the number of risk factors, in diabetes. RESULTS: ESKD incidence among patients with and without diabetes initially declined until 2007 and increased thereafter, whereas diabetic nephropathy decreased throughout follow-up. In patients with diabetes, baseline values for glycated hemoglobin, systolic blood pressure (SBP), triglycerides, and BMI were associated with outcomes. Hazard ratio (HR) for ESKD for patients with type 2 diabetes who had all included risk factors at target was 1.60 (95% CI 1.49-1.71) compared with control subjects and for patients with type 1 diabetes 6.10 (95% CI 4.69-7.93). Risk for outcomes increased in a stepwise fashion for each risk factor not at target. Excess risk for ESKD in type 2 diabetes showed a HR of 2.32 (95% CI 2.30-2.35) and in type 1 diabetes 10.92 (95% CI 10.15-11.75), compared with control. CONCLUSIONS: Incidence of diabetic nephropathy has declined substantially, whereas ESKD incidence has increased. Traditional and modifiable risk factors below target levels were associated with lower risks for outcomes, particularly notable for the causal risk factors of SBP and HbA1c, with potential implications for care.
引用
- Halminen J, Sattar N, Rawshani A, et al. Range of Risk Factor Levels, Risk Control, and Temporal Trends for Nephropathy and End-stage Kidney Disease in Patients With Type 1 and Type 2 Diabetes. Diabetes Care. 2022. PMID: 35984439. doi:10.2337/dc22-0926
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。